Cargando…
Guillain-Barré Syndrome with Rapid Onset and Autonomic Dysfunction Following First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report
Guillain-Barre syndrome (GBS) is an immune-mediated, often post-infectious illness manifesting as an acute, characteristically monophasic, polyradiculoneuropathy. We present a case of GBS with autonomic involvement following an mRNA-based vaccine against SARS-COV2 (Pfizer/BioNTech mRNA-BNT162b2). A...
Autores principales: | Lanman, Tyler Ashford, Wu, Connie, Cheung, Helen, Goyal, Neelam, Greene, Maxwell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977423/ https://www.ncbi.nlm.nih.gov/pubmed/35401916 http://dx.doi.org/10.1177/19418744211065242 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Guillain Barre Syndrome: case report
Publicado: (2021) -
Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases
por: Bouattour, Nadia, et al.
Publicado: (2021) -
A Case of Sequential Development of Polymyalgia Rheumatica and Guillain-Barré Syndrome Following Administration of the Pfizer-BioNTech COVID-19 Vaccine
por: Yamada, Shunsuke, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021)